This prospective before-and-after observational study investigated the effect of upper airway anaesthesia on dynamic airflow. Six consenting ASA 1 adults, all authors of this study, underwent a series of spirometric measurements before and after topical anaesthesia of the upper airway using lignocaine. Peak inspiratory flow rate, forced inspiratory flow between 25% and 75% of the maximum inhaled volume, forced expiratory volume at 1 second, and forced vital capacity in the supine and sitting positions were measured. The measured inspiratory parameters were significantly reduced after lignocaine topical anaesthesia of the upper airway. Expiratory flow parameters were not affected. We conclude that topical anaesthesia of the upper airway leads to dynamic inspiratory airflow limitation.
Fibreoptic bronchoscope-assisted tracheal intubation is an important technique in airway management. At the Prince of Wales Hospital, in non-anaesthetized patients, we typically instill lignocaine onto the pharynx, hypopharynx, and trachea to achieve airway anaesthesia prior to fibreoptic intubation 1 . As part of an ongoing evaluation of our technique and prompted by case reports [2] [3] [4] [5] and one case of our own 6 , of complete airway obstruction after topical lignocaine treatment in patients with pre-existing airway compromise, we measured the effects of upper airway anaesthesia on respiratory mechanics. The null hypothesis was that upper airway anaesthesia would have no effect on either inspiratory or expiratory airflow. We chose to perform our study using healthy adults with normal upper airways, because such studies in patients with pre-existing airway obstruction are not without danger and difficulties, and detecting changes in healthy volunteers would inform our understanding of the process. The sig-nificance that results derived from healthy volunteers would have for patients with compromised airways is unclear.
METHODS
Ethics approval was obtained from the Chinese University of Hong Kong. After initial attempts to recruit non-physician volunteers failed, participation in the experiment was invited from colleagues. In all, six participants volunteered, two principal investigators (AM-HH and DCC), one anaesthetist (MKK), one intensivist (CDG), one laboratory research fellow (ZP), and a pain specialist (BAT). All six participants (all ASA 1) signed informed consent to participate in the study. The hypothesis of the study was not discussed with the four volunteers, none of whom had a special interest in the subject (MKK had already finished his portion of the experiment by the time his name was added to the case report 6 published by AM-HH and colleagues). After all data had been collected, the volunteers were offered coauthorship, provided that they also participated in the preparation of the report. Prior to each experimental session, the fasted participant had a 22 gauge intravenous cannula sited and atropine 0.4 mg given intravenously. A senior anaesthetist not participating in the study monitored every session.
The experiment started with each participant practising several times with the spirometer. Baseline peak inspiratory flow rate (PIFR), forced inspiratory flow between 25% and 75% of the maximum inhaled volume (FIF 25-75 ), forced expiratory volume at one second, (FEV 1 ), and forced vital capacity (FVC) were recorded in both the supine and sitting positions. Next the participant's upper airway was anaesthetized using a previously described technique 1 . Briefly, this involved the supine subject gargling with 5 ml of lignocaine 2% twice, followed by instillation of lignocaine 1.5% 0.2 ml/kg into the pharynx. After each gargle and instillation, all excessive lignocaine was sucked out, such that the total lignocaine absorbed would be only be a fraction of the total applied amount (ie a fraction of about 5 to 7 mg/kg). Typically, aspiration occurred during the second gargle. After the topical airway anaesthesia step, the PIFR, FIF 25-75 , FEV 1 and FVC were measured again, first in the supine position and then in the sitting position at four reference times: immediately (0 minutes), then at 10 minutes, 20 minutes and 30 minutes. Each set of measurements was repeated three times and the best set was chosen for analysis. To minimize the effect of fatigue and to save time, we did not continue the measurements beyond 30 minutes.
Respiratory parameters were measured with the MedGraphics CPFS/D TM Portable Spirometer using BreezeSuite TM Software (St. Paul, MN, U.S.A.). This machine uses the differential pressure Pitot tube flowmeter principle 7 . The mouthpiece measures 3.5 cm in outer diameter and 3 cm in internal diameter, offering flow resistance of <1.20 cm H 2 O/ l/sec at 12 l/sec, and has a deadspace of 39 ml. Prior to each session, the machine was fully calibrated based on barometric pressure, room temperature and humidity. Although the machine measures bidirectional flow, the inspiratory parameters we intended to measure were conveniently displayed only in the expiratory mode. We therefore measured the parameters with the mouthpiece reversed.
Data at each measurement time point for each parameter (PIFR and FIF 25-75 ) were confirmed for normality using the Kolmogorov-Smirnov and the Sharpiro-Wilk tests with the level of significance set at P=0.05. The Mauchly's Test of Sphericity with the epsilon adjustment value to test the within-subject effects (time) after the sphericity assumption was applied was performed. The Levene's test of equality of error variance between the sitting and supine data was then used to verify that both groups of data followed the equality of variance assumption. Group statistics were then analysed using repeated measures ANOVA to test both between-subject (supine vs sitting) and within-subject (time) effects. Comparisons between different time points for the supine position were carried out using the test of within-subjects effects in repeated measures ANOVA. The same was done for data collected in the sitting position.
Sitting data were compared against supine data for each inspiratory parameter using the two-sample t-test after test of between-subject effects in repeated measures ANOVA had been completed.
RESULTS
The participants were six males [age: (mean±SD (range)): 44.7±8.8 (38-61) y, weight 76.8±6.9 (65-109) kg and height 169.2±7.1 (165-183) cm, respectively]. All attested to performing with maximum effort throughout and denied the presence of bias. Except for the inspiratory data at 30 minutes, all data were normally distributed. Group statistics using repeated measures ANOVA showed a significant difference (P<0.001) in both inspiratory parameters over the five different measurement time points, in both the supine and sitting positions. The data is graphically presented in Figure 1 . The effects were still evident after 30 minutes although all participants felt subjectively that the sensory impairment had noticeably waned by 15 to 30 minutes. Compared to the supine position, the sitting position was generally associated with higher flows and easier inspiration, although our study was not adequately powered to demonstrate statistical significance between flows in the two positions. Both inspiratory flow measurements showed a trend back to normality at 10 minutes after topicalization, but again, our study lacked enough power to demonstrate statistical significance. All volunteers tolerated the procedure well and compensated by breathing with their mouth wide open and avoiding sudden maximum inspiratory efforts except during measurements. The expiratory parameters FEV 1 and FVC were virtually identical before and after local anaesthesia. All participants tolerated oral intake two hours after the lignocaine anaesthesia.
DISCUSSION
Topical airway anaesthesia resulted in dynamic upper airflow limitation in healthy adults during maximum-effort inhalation. During inhalation, upper airway pressure is subatmospheric, creating a tendency for the pharynx and other upper airway soft tissue structures to collapse, in proportion to the magnitude of the inspiratory effort. This tendency is normally opposed by reflex contraction of pharyngeal dilator muscles (of which the major one is genioglossus) 8 . The afferent side of the reflex arises from mechanoreceptors in the larynx and pharynx 8 , mediated through the superior laryngeal, glossopharyngeal and lingual nerves. This mechanism is blocked by topical anaesthesia of those mechanoreceptors 8 . Animal studies demonstrate that laryngeal figure 1: Summary of peak inspiratory flow rate (PIFR) and forced inspiratory flow between 25% and 75% of the maximum inhaled volume (FIF 25-75 ), measured before local anaesthesia of upper airway and at 0 min (immediately), 10 min, 20 min, and 30 min after local anaesthesia instillation, in the supine and sitting positions. Data presented as mean±SD. *Significant decrease in magnitude from baseline (P<0.001). receptors help regulate laryngeal muscle activity, and laryngeal anaesthesia decreases upper airway muscle contractions during inspiration 9, 10 . In alert normal subjects, Liistro and colleagues 11 found that after upper airway anaesthesia, maximum inspiratory flows, flowvolume curves, supraglottic airway pressures, and supraglottic flow rates were decreased by amounts similar to ours for less than 45 minutes. Similarly, Kuna and colleagues 12 found decrease of upper airway calibre after upper airway anaesthesia. These authors 11, 12 proposed that local anaesthetic depresses laryngeal muscles, resulting in perturbed vocal cord motion, and that interference by lignocaine with the activity of specific receptors located in the upper airway, especially at the laryngeal level, results in the loss of the normally coordinated reflex opposition to the tendency of the upper airway mucosa to collapse during inspiration. Several cases of severe upper airway obstruction after airway anaesthesia in patients with previously compromised airway have been reported 2-6 . All participants reported that topical anaesthesia was noticeable within several minutes of instilling lignocaine, and that the experience was unpleasant because of the choking sensation and the impairment of inspiratory breathing, which was partially compensated by widely opening the mouth. There was subjective improvement as early as 15 to 30 minutes after upper airway anaesthesia.
PIFR (litres per second)
This study could be criticized for the lack of a control group; for example a group given a placebo such as saline. We considered that the distinctive taste and obvious sensory effect of lignocaine made the use of a placebo pointless as it would have been impossible to blind the participants. Another potential source of bias was that the participants were authors of this report. As stated in the Methods section, the third to sixth authors started as volunteers and none was familiar with the topic and the hypothesis. Co-authorship was offered only after data collection.
Two aspects of the data support the idea that the subjects were not biased when performing the tests. Two findings were consistent but either unexpected or unknown to the participants. It would be most unlikely that the participants could "tailor their efforts" to create these results (either consciously or unconsciously). These results were that, unlike inspiratory flows, expiratory flows were unaffected, and the recovery trend started as early as 10 minutes after topicalization. Neither finding was common knowledge. That said, it is probably fair to say that non-physicians would have made better participants.
Finally, this study was on healthy subjects with no upper airway pathology, when in fact, it is those patients with airway compromise that require topicalization for fibreoptic intubation. After all, airway obstruction after topical anaesthesia has apparently never been reported in patients without compromising airway pathology. Given the case reports 2-6 , one of which involved our own patient 6 , documenting the danger of airway obstruction, we felt it would have been unethical to conduct this study on patients with upper airway compromise. Extrapolation of our results to such patients, while it seems reasonable, remains unproven. Maximum effort inhalation associated with panic, coughing, sneezing and choking could dangerously impair gas flow after upper airway anaesthesia. Use of pharyngeal airways, positive pressure ventilation, and continuous positive airway pressure augmented spontaneous respiration may counteract dynamic airway narrowing, but may either induce coughing in a non-anaesthetized person or interfere with local anaesthetic application. Anaesthetizing the patient prior to application of local anaesthetic and any form of instrumentation, as is often the practice in children and in certain upper airway procedures, would avoid dynamic airway narrowing, but is not without pitfalls in a patient with pre-existing partial upper airway obstruction. A mask that accommodates upper airway application of local anaesthetic, and intubation of the trachea with a fibrescope and a tracheal tube whilst maintaining continuous positive pressure-augmented breathing is under development by our team. Consideration should be given to awake tracheostomy in a patient with severe upper airway obstruction. Our experience also suggests that fibreoptic intubation and other planned upper airway instrumentation should proceed without delay after lignocaine 1.5 to 2% instillation, and supplemental anaesthesia may be required by 15 to 30 minutes. Patients may no longer enjoy adequate upper airway anaesthesia 30 minutes after instillation of lignocaine and therefore could react to the presence of a tracheal tube or foreign body if instrumentation were continued and if general anaesthesia were terminated at that point.
In conclusion, maximum inspiratory flow is impeded by the effects of topical local anaesthetic in the upper airway. Although our study involved normal subjects, this information, combined with case reports of airway obstruction being induced by topical airway anaesthesia in patients with airway obstruction, suggests that clinicians should exercise caution when inducing local anaesthesia in patients with pre-existing upper airway obstruction.
